Male Contraception.
Journal
Seminars in reproductive medicine
ISSN: 1526-4564
Titre abrégé: Semin Reprod Med
Pays: United States
ID NLM: 100909394
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
pubmed:
20
12
2023
medline:
20
12
2023
entrez:
19
12
2023
Statut:
ppublish
Résumé
Approximately 40 to 50% of pregnancies are unintended. Contraceptive use significantly reduces the risk of unintended pregnancy. Approximately 70% of couples' contraceptive use is female and 30% is male, attributable to the reliance on condoms and vasectomies. Unfortunately, many women cannot use currently available contraceptives due to medical contraindications or side effects. At the same time, men want additional safe and effective contraceptive methods. Because of this, work to develop novel, safe, and effective male contraceptives is underway. This review will briefly discuss the pros and cons of condoms and vasectomies, and then describe research into the development of novel methods of male contraception, by the mechanism of action of the contraceptive. First, we will discuss male contraceptives that block sperm transmission. Next, we will discuss male contraceptives that impair sperm production. Lastly, we will discuss male contraceptives that impair sperm function.
Identifiants
pubmed: 38113922
doi: 10.1055/s-0043-1777757
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
279-286Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
None declared.